Resolution of clinical and pathologic features of C1q nephropathy after rituximab therapy

Clinical and Experimental Nephrology

Volumn 15, Issue 1, 2011, Pages 164-170

  Sinha, Aditi ^a   Nast, Cynthia C ^b   Hristea, Ionut ^a   Vo, Ashley A ^a   Jordan, Stanley C ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti CD20; C1qN

Indexed keywords

AMIODARONE; CALCIUM CARBONATE; CARVEDILOL; CD20 ANTIBODY; COMPLEMENT COMPONENT C1Q; CORTICOSTEROID; FLUCONAZOLE; HYDROCORTISONE; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; INSULIN; LEVOTHYROXINE; METOCLOPRAMIDE; MULTIVITAMIN; MYCOPHENOLIC ACID; PANTOPRAZOLE; PREDNISONE; RAMIPRIL; RECOMBINANT ERYTHROPOIETIN; RITUXIMAB; SEVELAMER; SUCRALFATE; TIMOLOL; VERAPAMIL; WARFARIN;

ADRENAL INSUFFICIENCY; ADULT; ANASARCA; ARTICLE; C1Q NEPHROPATHY; CASE REPORT; CHILD; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; GLOMERULOPATHY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEMATURIA; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HYPERTENSION; HYPOTHYROIDISM; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INTRAOCULAR HYPOTENSION; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LEG SWELLING; LIVER CELL CARCINOMA; MALE; NAUSEA; OUTCOME ASSESSMENT; PATIENT REFERRAL; PROTEINURIA; REMISSION; REPEATED DRUG DOSE; SCHOOL CHILD; THRUSH; VOMITING;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; CHILD; COMPLEMENT C1Q; FEMALE; GLOMERULAR MESANGIUM; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED;

EID: 79952190280     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0377-x     Document Type: Article

References (21)

1. A Mii A Shimizu Y Masuda E Fujita K Aki M Ishizaki, et al. 2009 Current status and issues of C1q nephropathy Clin Exp Nephrol 13 263 274 1:CAS:528:DC%2BD1MXhtF2isbvE 10.1007/s10157-009-0159-5 19373520
2. KK Lau LW Gaber NM Delos Santos RJ Wyatt 2005 C1q nephropathy: features at presentation and outcome Pediatr Nephrol 20 744 749 10.1007/s00467-004-1810-8 15827744 (Pubitemid 40663156)
3. GS Markowitz JA Schwimmer MB Stokes S Nasr RL Seigle AM Valeri, et al. 2003 C1q nephropathy: a variant of focal segmental glomerulosclerosis Kidney Int 64 1232 1240 1:CAS:528:DC%2BD3sXotFyrtb0%3D 10.1046/j.1523-1755.2003.00218.x 12969141 (Pubitemid 37153788)
4. MS Ahmed CF Wong 2008 Rituximab and nephrotic syndrome: a new therapeutic hope? Nephrol Dial Transpl 23 11 17 10.1093/ndt/gfm683 (Pubitemid 351767420)
5. T Yang CC Nast A Vo SC Jordan 2008 Rapid remission of steroid and mycophenolate mofetil (MMF)-resistant minimal change nephrotic syndrome after rituximab therapy Nephrol Dial Transpl 23 377 380 10.1093/ndt/gfm592 (Pubitemid 351767391)
6. PP Sfikakis JN Boletis S Lionaki V Vigklis KG Fragiadaki A Iniotaki, et al. 2005 Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial Arthritis Rheum 52 501 513 1:CAS:528: DC%2BD2MXit1GjtLo%3D 10.1002/art.20858 15693003 (Pubitemid 40216314)
7. M Bitzan JD Ouahed P Krishnamoorthy C Bernard 2008 Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution Pediatr Nephrol 23 1355 1361 10.1007/s00467-008-0781-6 18351394
8. JC Jennette CG Hipp 1985 C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome Am J Kidney Dis 6 103 110 1:STN:280:DyaL2M3ns1altw%3D%3D 3875286 (Pubitemid 15017774)
9. SS Iskandar MC Browning WB Lorentz 1991 C1q nephropathy: a pediatric clinicopathologic study Am J Kidney Dis 18 459 465 1:STN:280: DyaK38%2Fis1Smsw%3D%3D 1928065
10. A Vizjak D Ferluga M Rozic A Hvala J Lindic TK Levart, et al. 2008 Pathology, clinical presentations, and outcomes of C1q nephropathy J Am Soc Nephrol 19 2237 2244 10.1681/ASN.2007080929 18650484
11. S Hisano Y Fukuma Y Segawa K Niimi Y Kaku K Hatae, et al. 2008 Clinicopathologic correlation and outcome of C1q nephropathy Clin J Am Soc Nephrol 3 1637 1643 10.2215/CJN.00830208 18650410
12. R Marcus A Hagenbeek 2007 The therapeutic use of rituximab in non-Hodgkin's lymphoma Eur J Haematol Suppl 67 5 14 1:CAS:528: DC%2BD2sXitlCgt7k%3D 10.1111/j.1600-0609.2006.00789.x 17206982 (Pubitemid 44934857)
13. RD Gilbert E Hulse S Rigden 2006 Rituximab therapy for steroid dependent minimal change nephrotic syndrome Pediatr Nephrol 21 1698 1700 10.1007/s00467-006-0228-x 16932900 (Pubitemid 44390835)
14. A Bagga A Sinha A Moudgil 2007 Rituximab in patients with the steroid-resistant nephrotic syndrome N Engl J Med 356 2751 2752 1:CAS:528:DC%2BD2sXnt1aisb8%3D 10.1056/NEJMc063706 17596616 (Pubitemid 47001064)
15. MD Pescovitz BK Book RA Sidner 2006 Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment N Engl J Med 354 1961 1963 1:CAS:528:DC%2BD28XksVarsro%3D 10.1056/NEJMc055495 16672715 (Pubitemid 43872718)
16. G Fernandez-Fresnedo A Segarra E González S Alexandru R Delgado N Ramos, et al. 2009 Trabajo de Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN): rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis Clin J Am Soc Nephrol 4 1317 1323 1:CAS:528:DC%2BD1MXhtV2qur3J 10.2215/CJN.00570109 19578004
17. A Segarra M Praga N Ramos N Polanco I Cargol E Gutierrez-Solis, et al. 2009 Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patients Clin J Am Soc Nephrol 4 1083 1088 1:CAS:528:DC%2BD1MXnsF2rur4%3D 10.2215/CJN.06041108 19478097
18. SP Berger A Roos MR Daha 2005 Complement and the kidney: what the nephrologists needs to know in 2006? Nephrol Dial Transpl 20 2613 2619 10.1093/ndt/gfi166 (Pubitemid 41672257)
19. MP Soares FH Bach 1999 C1q receptors and endothelial cell activation J Lab Clin Med 133 520 522 1:STN:280:DyaK1M3osleluw%3D%3D 10.1016/S0022-2143(99) 90179-8 10360624 (Pubitemid 29257212)
20. S Uwatoko S Aotsuka M Okawa Y Egusa R Yokohari C Aizawa, et al. 1984 Characterization of C1q-binding IgG complexes in systemic lupus erythematosus Clin Immunol Immunopathol 30 104 116 1:STN:280:DyaL2c7jtVKrug%3D%3D 10.1016/0090-1229(84)90011-4 6421520 (Pubitemid 14219649)
21. B Hauptrock G Hess 2008 Rituximab in the treatment of non-Hodgkin's lymphoma Biologics 4 619 633